Latest Period
Q1 2026
Security Snapshot
INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (INO) Institutional Ownership
CUSIP: 45773H409
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026
Institutions Reporting
99
Shares (Excl. Options)
31,364,867
Price
$1.74
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- INO on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 31,364,867
- Total 13F value
- $54,590,706
- Portfolio coverage rank
- 0%
- Share change
- -1,619,887
- Value change
- -$2,795,836
- Number of holders
- 99
- Shares outstanding
- 75,493,598
- SEC-reported price per share
- $1.34
- Insider filing price
- $1.34
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 45773H409.
- 99 institutions reported positions in Q1 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 100 to 99 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $57,545,745 to $54,590,706.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 99 institutions filings for Q1 2026.
Security key
45773H409
Latest holder period
Q1 2026
13F holders
99
13D/G owners
9
CIK / CUSIP context first
Open Q1 2026 holders
INO full holder history
INOVIO PHARMACEUTICALS, INC. SEC filings
INOVIO PHARMACEUTICALS, INC. company facts
INOVIO PHARMACEUTICALS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45773H409:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
INO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 14% | -8.7% | $10,553,764 | -$572,966 | 9,339,614 | -5.1% | FMR LLC | 31 Mar 2026 |
| JANUS HENDERSON GROUP PLC | 10% | +63% | $12,999,275 | +$6,630,068 | 6,666,295 | +104% | JANUS HENDERSON GROUP PLC | 28 Nov 2025 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 8.2% | -11% | $6,995,237 | +$2,889,570 | 6,190,475 | +70% | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31 Mar 2026 |
| Adage Capital Management, L.P. | 5.8% | -42% | $4,783,888 | -$1,451,057 | 4,233,529 | -23% | Adage Capital Management, L.P. | 31 Mar 2026 |
| Alyeska Investment Group, L.P. | 6% | -19% | $6,400,000 | 4,000,000 | 0% | Alyeska Investment Group, L.P. | 31 Dec 2025 | |
| VANGUARD GROUP INC | 5% | -9.5% | $5,769,107 | +$2,238,719 | 3,315,579 | +63% | The Vanguard Group | 31 Dec 2025 |
| Stonepine Capital Management, LLC | 3.8% | -28% | $2,683,444 | -$900,721 | 1,434,997 | -25% | Stonepine Capital Management, LLC | 31 Mar 2025 |
| Deep Track Capital, LP | 2.4% | $3,076,623 | 1,314,796 | Deep Track Capital, LP | 30 Sep 2025 | |||
| BlackRock, Inc. | 1.5% | -80% | $1,099,608 | -$3,642,379 | 537,627 | -77% | BlackRock, Inc. | 30 Jun 2025 |
As of 31 Mar 2026, 99 institutional investors reported holding 31,364,867 shares of INOVIO PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (INO). This represents 42% of the company’s total 75,493,598 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
41%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 12% | 9,339,614 | -5.1% | 0% | $16,250,928 |
| JANUS HENDERSON GROUP PLC | 4.4% | 3,308,406 | 0% | 0% | $5,773,168 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 2,901,208 | 0% | 0% | $5,048,102 |
| Boxer Capital Management, LLC | 3.1% | 2,370,122 | -2.1% | 0.54% | $4,124,012 |
| D. E. Shaw & Co., Inc. | 2.9% | 2,212,819 | -0.85% | 0% | $3,850,305 |
| ADAR1 Capital Management, LLC | 1.9% | 1,470,108 | -1% | 0.16% | $2,557,988 |
| MILLENNIUM MANAGEMENT LLC | 1.9% | 1,410,845 | +0.53% | 0% | $2,454,870 |
| Eversept Partners, LP | 1.4% | 1,035,360 | 0.12% | $1,801,526 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.1% | 804,958 | -68% | 0% | $1,400,627 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 801,504 | +4.2% | 0% | $1,395,687 |
| BlackRock, Inc. | 0.88% | 662,181 | +7.2% | 0% | $1,152,195 |
| RENAISSANCE TECHNOLOGIES LLC | 0.85% | 643,777 | +16% | 0% | $1,120,172 |
| DIADEMA PARTNERS LP | 0.75% | 562,665 | +5.4% | 0.44% | $979,037 |
| VANGUARD FIDUCIARY TRUST CO | 0.52% | 392,066 | 0% | 0% | $682,195 |
| TWO SIGMA INVESTMENTS, LP | 0.52% | 390,384 | +21% | 0% | $679,268 |
| NORTHERN TRUST CORP | 0.4% | 298,870 | -0.37% | 0% | $520,034 |
| STATE STREET CORP | 0.39% | 296,310 | +20% | 0% | $515,579 |
| CITADEL ADVISORS LLC | 0.38% | 286,352 | 0% | $498,252 | |
| GSA CAPITAL PARTNERS LLP | 0.35% | 265,075 | -42% | 0.03% | $461,000 |
| UBS Group AG | 0.33% | 249,650 | +46% | 0% | $434,392 |
| 683 Capital Management, LLC | 0.33% | 248,790 | 0% | 0.04% | $432,895 |
| XTX Topco Ltd | 0.28% | 212,677 | +27% | 0.01% | $370,058 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.23% | 173,000 | 0% | 0.01% | $301,020 |
| Persistent Asset Partners Ltd | 0.19% | 142,164 | 0% | 0.1% | $247,365 |
| GMT Capital Corp | 0.17% | 126,119 | 0.01% | $219,447 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q1 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 31,364,867 | $54,590,706 | -$2,795,836 | $1.74 | 99 |
| 2025 Q4 | 33,075,777 | $57,545,745 | +$21,224,322 | $1.74 | 100 |
| 2025 Q3 | 20,711,886 | $48,449,935 | +$25,433,512 | $2.34 | 98 |
| 2025 Q2 | 10,168,502 | $20,694,831 | -$6,577,397 | $2.04 | 101 |
| 2025 Q1 | 13,600,161 | $22,159,691 | +$51,992 | $1.63 | 105 |
| 2024 Q4 | 13,346,624 | $24,424,740 | +$7,463,553 | $1.83 | 100 |
| 2024 Q3 | 8,566,045 | $49,511,575 | +$2,096,827 | $5.78 | 95 |
| 2024 Q2 | 8,056,972 | $65,100,837 | +$29,640,224 | $8.08 | 92 |
| 2024 Q1 | 4,044,287 | $56,123,192 | +$53,680,856 | $13.88 | 83 |
| 2023 Q4 | 298,900 | $152,940 | +$152,930 | $0.51 | 7 |